Heterocyclic rimantadine analogues with antiviral activity

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 24, 2003, Pages 5485-5492

  Stamatiou, George ^a   Foscolos, George B ^a   Fytas, George ^a   Kolocouris, Antonios ^a   Kolocouris, Nicolas ^a   Pannecouque, Christophe ^b   Witvrouw, Myriam ^b   Padalko, Elizaveta ^b   Neyts, Johan ^b   Clercq, Erik De ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYLMETHYL 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)PIPERIDINE; 1 METHYL 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)PIPERIDINE; 1 PHENYLMETHYL 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)PIPERIDINE; 1 [2 (1 PIPERIDINE)ETHYL] 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)HEXAHYDRO 1H AZEPINE; 1 [2 (1 PIPERIDINO)ETHYL] 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)PIPERIDINE; 1 [2 (DIMETHYLAMINO)ETHYL] 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)PIPERIDINE; 2 (1 ADAMANTYL)PYRROLIDINE DERIVATIVE; 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL)PIPERIDINE; AMANTADINE; HEXAHYDRO 1 METHYL 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL) 1H AZEPINE; HEXAHYDRO 2 (TRICYCLO[3.3.1.1 3,7 ]DEC 1 YL) 1H AZEPINE; NEVIRAPINE; RIBAVIRIN; RIMANTADINE; RIMANTADINE DERIVATIVE; RITONAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; PHARMACOPHORE; STRUCTURE ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0344851554     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.09.024     Document Type: Article

References (29)

1. Cox N.J., Subarao K. Lancet. 354:1999;1277.
2. (a) Simonsen L., Schonberger L.B., Stroup D.F., Arden N.H., Cox N.J. The Impact of Influenza on Mortality in the USA. Brown L.E., Hampson A.W., Webster R.G. Options for the Control of Influenza III. 1996;26 Elsevier Science, Amsterdam,
3. (b) Lui K.-J., Kendal A.P. Am. J. Public Health. 77:1987;712.
4. (a) Taubenberger J.K., Reid A.H., Fanning T.G. Virology. 274:2000;241
5. (b) Taubenberger J.K., Reid A.H., Kraftt A.E., Bijwaard K.E., Fanning T.G. Science. 275:1997;1793.
6. Horimoto T., Kawaoka Y. Clin. Microb. Rev. 14:2001;129.
7. (a) Pinto L.H., Holsinger L.J., Lamb R.A. Cell. 69:1992;517
8. (b) Duff K.C., Gilchrist P.J., Saxena A.M., Bradshaw J.P. Virology. 188:1992;14
9. (c) Gandhi C.S., Shuck K., Lear J.D., Dieckmann G.R., DeGrado W.F., Lamb R.A., Pinto L.H. J. Biol. Chem. 274:1999;5474
10. (d) Hay A.J. Semin. Virol. 3:1992;21.
11. Laughlin C.A., Tseng C.K. Antivirals Agents, RNA Viruses Other than HIV. Wolff M.E. Burger's Medicinal Chemistry. 5th ed. 1997;571 John Wiley & Sons, New York. Vol. 5.
12. (a) Kolocouris N., Foscolos G.B., Kolocouris A., Marakos P., Pouli N., Fytas G., Ikeda S., DeClercq E. J. Med. Chem. 37:1994;2896
13. (b) Kolocouris N., Kolocouris A., Foscolos G.B., Fytas G., Neyts J., Padalko E., Balzarini J., Snoeck R., Andrei G., De Clercq E. J. Med. Chem. 39:1996;3307
14. (c) Fytas G., Foscolos G., Stamatiou G., Kolocouris A., Kolocouris N., Witvrouw M., Pannecouque C., De Clercq E. Bioorg. Med. Chem. Lett. 7:1997;1887
15. (d) Kolocouris A., Tatarides D., Fytas G., Foscolos G., Mavromoustakos T., Kolocouris N. Bioorg. Med. Chem. Lett. 9:1999;3465
16. (e) Stamatiou G., Kolocouris A., Kolocouris N., Fytas G., Foscolos G.B., Neyts J., De Clercq E. Bioorg. Med. Chem. Lett. 11:2001;2137
17. (f) Stylianakis I., Kolocouris A., Kolocouris N., Fytas G., Foscolos G.B., Padalko E., Neyts J., DeClercq E. Bioorg. Med. Chem. Lett. 11:2003;1699
18. (g) Zoidis G., Kolocouris N., Foscolos G.B., Kolocouris A., Fytas G., Karayannis P., Padalko E., Neyts J., De Clercq E. Antiviral Chem. Chemother. 14:2003;155.
19. Borch R.F., Hassid I. J. Org. Chem. 37:1972;1673.
20. Fytas G., Kolocouris N., Foscolos G.B., Vamvakides A. Eur. J. Med. Chem. 26:1991;563.
21. Astier A., Plat M. Tetrahedron Lett. 1978;2051.
22. Pinna G.A., Cignarella G., Scolastico S., Porceddu M.L. Eur. J. Med. Chem. 29:1994;55.
23. Kraus G.A., Siclovan T.M. J. Org. Chem. 359:1990;922.
24. Shigeta S., Konno K., Yokota T., Nakamura K., De Clercq E. Antimicrob. Agents Chemother. 32:1998;906.
25. Barré-Sinoussi F., Chermann J.C., Nugeyre M.T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. Science. 220:1983;868.
26. Miyoshi I., Taguchi H., Kobonishi I., Yoshimoto S., Ohtsuki Y., Shiraishi Y., Akagi T. Gann. Monogr. 28:1982;219.
27. Popovic M., Sarngadharan M.G., Read E., Gallo R.C. Science. 224:1984;497.
28. Pauwels R., De Clercq E., Desmyter J., Balzarini J., Goubau P., Herdewijn P., Vanderhaeghe H., Vandeputte M. J. Virol. Methods. 16:1987;171.
29. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. J. Virol. Methods. 20:1988;309.